Clinical trial
Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly…
NCT00307528 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00307528 |
|---|---|
| Title | Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population |
| Official title | A Study to Evaluate the Safety, Reactogenicity & Immunogenicity of the GSK Biologicals Candidate Pneumococcal Vaccine Without or With Adjuvant, Administered at 2 Different Concentrations, in Healthy Elderly Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prophylaxis Invasive Pneumococcal Diseases and Pneumonia |
| Intervention type | Biological |
| Interventions | Pneumococcal vaccine GSK513026, Pneumovax 23™ |
| Enrollment | 146 |
| Start date | Jan 20, 2004 |
| Primary completion | Mar 30, 2005 |
| Completion | Mar 30, 2005 |
| First posted | Mar 28, 2006 |
| Last update posted | Oct 30, 2019 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: